Yeah I did notice that but I was too focused on the revenue timeline. Once again, the other cancers are great but their development ultimately needs Colostat to fund it. They have to get off their behinds and sell the bloody thing. I'm sure once Doctors, patients, companies see the benefits of NOT having to reach for the colonoscopy handle every time the FOB comes up positive - it will sell and sell well.
RHY Price at posting:
47.0¢ Sentiment: Hold Disclosure: Not Held
